Dr. Subroto Chatterjee is a professor of pediatrics at the Johns Hopkins University School of Medicine. He is an internationally recognized expert in glycolipids, atherosclerosis and vascular biology. His research team recently discovered how to halt the development of atherosclerotic heart disease in animals. Dr. Chatterjee serves as the director of the Sphingolipid Signaling and Vascular Biology Laboratory. His team is currently studying how glycosphinglipids in vascular cells regulate the onset of atherosclerosis and hypercholesterolemia. Dr. Chatterjee received his undergraduate degree in chemistry from Lucknow University in India. He earned his M.Sc. in biochemistry from Lucknow University, his M.S. in biochemistry from Dalhousie University in Canada, and his Ph.D. in biochemistry from the University of Toronto. He completed a post-doctoral fellowship in biochemistry at Michigan State University. Dr. Chatterjee joined the Johns Hopkins faculty in 1975. Prior to joining Johns Hopkins, Dr. Chatterjee was a research associate at Michigan State University. He served as the director of the Atherosclerosis and Vascular Biology Program at Johns Hopkins Singapore for five years.